Full Press Release Details
ANDOVER, Mass. , Feb. 17, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX ), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the TD Cowen 46 th Annual Health Care Conference in Boston on Monday, March 2, 2026, at 1:50 p.m. EST and virtually at the Oppenheimer 36 th Annual Healthcare MedTech & Services Conference on Monday, March 16, 2026, at 10:00 a.m. EST.
Event: TD Cowen 46 th Annual Health Care Conference Date: Monday, March 2, 2026 Time: 1:50 p.m. EST
Event: Oppenheimer 36 th Annual Healthcare MedTech & Services Conference Date: Monday, March 16, 2026 Time: 10:00 a.m. EST
A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/ . The Company's standard investor presentation is also available through this link.
About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact: Brian Johnston Laine Morgan 332-895-3222 [email protected]
SOURCE TransMedics Group, Inc.